tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Legend Biotech’s Strategic Growth and Risks: Analyst Assigns Hold Rating
PremiumRatingsLegend Biotech’s Strategic Growth and Risks: Analyst Assigns Hold Rating
12d ago
Legend Biotech Reports Strong Q3 2025 Results and CARVYKTI® Progress
Premium
Company Announcements
Legend Biotech Reports Strong Q3 2025 Results and CARVYKTI® Progress
12d ago
Legend Biotech reports Q3 adjusted EPS (5c), consensus (12c)
Premium
The Fly
Legend Biotech reports Q3 adjusted EPS (5c), consensus (12c)
12d ago
Legend Biotech price target lowered to $60 from $75 at H.C. Wainwright
PremiumThe FlyLegend Biotech price target lowered to $60 from $75 at H.C. Wainwright
1M ago
Legend Biotech’s CARVYKTI® Receives FDA Approval for Label Update with New Survival Data
Premium
Company Announcements
Legend Biotech’s CARVYKTI® Receives FDA Approval for Label Update with New Survival Data
1M ago
Legend Biotech Reports Strong CARVYKTI® Sales for Q3 2025
Premium
Company Announcements
Legend Biotech Reports Strong CARVYKTI® Sales for Q3 2025
1M ago
Legend Biotech assumed with an Overweight at Cantor Fitzgerald
PremiumThe FlyLegend Biotech assumed with an Overweight at Cantor Fitzgerald
3M ago
Legend Biotech price target raised to $78 from $77 at JPMorgan
Premium
The Fly
Legend Biotech price target raised to $78 from $77 at JPMorgan
3M ago
Legend Biotech Appoints Carlos Santos as CFO to Drive Financial Strategy
Premium
Company Announcements
Legend Biotech Appoints Carlos Santos as CFO to Drive Financial Strategy
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100